Atlas Trials

Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

Clinical trial NCT05473520 · RECRUITING

Trial details

NCT number
NCT05473520
Sponsor
National University Hospital, Singapore
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
TuberculosisAcute Coronary SyndromePulmonary Hypertension (Diagnosis)
Start date
2023-05-24
Primary completion
2030-01-31
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.